Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRRC39 Inhibitors

LRRC39, or Leucine Rich Repeat Containing 39, is a protein encoded by the LRRC39 gene in humans. Proteins in this family are characterized by leucine-rich repeat (LRR) domains. These domains typically consist of 20-30 amino acids and are rich in leucine, forming a structural motif that participates in protein-protein interactions.The exact function of the LRRC39 protein is not fully characterized, but leucine-rich repeat containing proteins are known to be involved in a variety of cellular functions, including signal transduction, cell adhesion, DNA repair, recombination, and regulation of gene expression. They are often key players in the immune response and development.

LRR-containing proteins can act as receptors or adaptor molecules that mediate specific ligand-receptor interactions. These interactions can trigger signal transduction pathways that culminate in a cellular response, such as the modulation of the cell cycle, apoptosis, or immune responses. Due to the versatility of the LRR domain in mediating protein-protein interactions, LRRC39 may engage in diverse functional complexes, affecting various signaling pathways or structural assemblies.Given the prominence of LRR motifs in a range of proteins with known functions, LRRC39 might be implicated in one or several of these processes. However, without specific studies detailing its expression pattern, interacting partners, or effects of gene knockdowns or mutations, the precise biological role of LRRC39 remains to be elucidated. Research into LRRC39 and similar leucine-rich repeat proteins continues to expand our understanding of cellular function and the intricate networks of protein interactions that underpin cellular physiology and the response to environmental cues. Insights into such proteins may reveal new aspects of cell biology and potential implications for disease mechanisms, diagnostics.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D may inhibit LRRC39 expression by intercalating into DNA, blocking RNA synthesis and affecting transcription of LRRC39.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide might inhibit LRRC39 expression by blocking protein synthesis, thereby reducing the production of LRRC39 protein.

Chromomycin A3

7059-24-7sc-200907
10 mg
$255.00
(1)

Actinomycin C could potentially inhibit LRRC39 expression similarly to Actinomycin D, by interfering with RNA synthesis.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin may inhibit LRRC39 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of LRRC39.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Puromycin might inhibit LRRC39 expression by prematurely terminating protein synthesis, thereby reducing LRRC39 production.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin has been suggested to inhibit LRRC39 expression by inhibiting protein synthesis at the translational level, affecting LRRC39 production.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin may inhibit LRRC39 expression by intercalating into DNA and impacting transcription, reducing the synthesis of LRRC39.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide could potentially inhibit LRRC39 expression by affecting topoisomerase II activity, influencing DNA transcription and LRRC39 synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$360.00
$475.00
20
(2)

Blasticidin S may inhibit LRRC39 expression by interfering with protein synthesis, potentially reducing the production of LRRC39.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Mitomycin C might inhibit LRRC39 expression by crosslinking DNA, affecting transcription and potentially reducing LRRC39 synthesis.